Search Results - "Patti, Giuseppe"
-
1
The Role of Clopidogrel in 2020: A Reappraisal
Published in Cardiovascular therapeutics (2020)“…Antiplatelet therapy is the mainstay of treatment and secondary prevention of cardiovascular disease (CVD), including acute coronary syndrome (ACS), transient…”
Get full text
Journal Article -
2
Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy
Published in Pharmacology & therapeutics (Oxford) (01-01-2018)“…Stem cells have the potential to differentiate into cardiovascular cell lineages and to stimulate tissue regeneration in a paracrine/autocrine manner; thus,…”
Get full text
Journal Article -
3
The Usefulness of Cardiopulmonary Exercise Testing to Detect Functional Improvement after Transcatheter Valve Procedures: What Do We Know So Far?
Published in Reviews in cardiovascular medicine (01-09-2024)“…Transcatheter valve procedures have become a cornerstone in the management of patients with valvular heart disease and high surgical risk, especially for…”
Get full text
Journal Article -
4
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention
Published in European heart journal (14-07-2015)“…Although platelet reactivity during P2Y12-inhibitors is associated with stent thrombosis (ST) and bleeding, standardized and clinically validated thresholds…”
Get full text
Journal Article -
5
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19
Published in Scientific reports (22-11-2021)“…Many coronavirus disease 2019 (Covid-19) survivors show symptoms months after acute illness. The aim of this work is to describe the clinical evolution of…”
Get full text
Journal Article -
6
Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub‐Analysis From the PREFER in AF (PREvention oF Thromboembolic Events–European Registry in Atrial Fibrillation)
Published in Journal of the American Heart Association (01-07-2017)“…Background Increasing age predisposes to both thromboembolic and bleeding events in patients with atrial fibrillation; therefore, balancing risks and benefits…”
Get full text
Journal Article -
7
Research into New Molecular Mechanisms in Thrombotic Diseases Paves the Way for Innovative Therapeutic Approaches
Published in International journal of molecular sciences (21-02-2024)“…Thrombosis is a multifaceted process involving various molecular components, including the coagulation cascade, platelet activation, platelet-endothelial…”
Get full text
Journal Article -
8
Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study)
Published in The American journal of cardiology (01-04-2011)“…Platelet reactivity predicts ischemic outcomes in patients who undergo percutaneous coronary intervention (PCI), but the correlation of heightened platelet…”
Get full text
Journal Article -
9
Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty–Contrast-Induced Nephropathy] Trial
Published in The American journal of cardiology (01-07-2011)“…Contrast-induced nephropathy (CIN) impairs clinical outcome in patients undergoing angiographic procedures. The aim of this study was to investigate whether…”
Get full text
Journal Article -
10
Efficacy and safety of eplerenone in the management of mild to moderate arterial hypertension: Systematic review and meta-analysis
Published in International journal of cardiology (15-11-2014)“…Abstract Background The role of eplerenone in arterial hypertension has been investigated only in small studies. To systematically assess the efficacy and…”
Get full text
Journal Article -
11
Combining Antiplatelet and Anticoagulant Therapies
Published in Journal of the American College of Cardiology (07-07-2009)“…Antiplatelet therapy is the cornerstone for both primary and secondary prevention therapies for ischemic events resulting from coronary atherosclerotic…”
Get full text
Journal Article -
12
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry
Published in PloS one (15-07-2019)“…Despite great advances with the introduction of ticagrelor and prasugrel in the treatment of acute coronary syndromes (ACS), the risk of thrombosis and…”
Get full text
Journal Article -
13
Extended Duration Dual Antiplatelet Therapy in Patients with Myocardial Infarction: a study-level meta-analysis of controlled randomized trials
Published in The American heart journal (01-06-2016)“…Abstract Background Whether dual antiplatelet therapy (DAPT) is beneficial beyond one year after myocardial infarction (MI) is not demonstrated; in particular,…”
Get full text
Journal Article -
14
Low platelet count at admission has an adverse impact on outcome in patients with acute coronary syndromes: from the START Antiplatelet registry
Published in Scientific reports (24-06-2024)“…Some previous observations suggest that a low platelet count is associated with an increased risk of adverse outcomes in patients with acute coronary syndromes…”
Get full text
Journal Article -
15
Meta-Analysis of Net Long-Term Benefit of Different Therapeutic Strategies in Patients With Cryptogenic Stroke and Patent Foramen Ovale
Published in The American journal of cardiology (15-03-2015)“…We pooled available data on follow-up events in patients with patent foramen ovale and cryptogenic stroke to evaluate the net clinical benefit of different…”
Get full text
Journal Article -
16
Usefulness of Statin Pretreatment to Prevent Contrast-Induced Nephropathy and to Improve Long-Term Outcome in Patients Undergoing Percutaneous Coronary Intervention
Published in The American journal of cardiology (01-02-2008)“…Contrast-induced nephropathy (CIN) is an important cause of mortality and morbidity in patients undergoing angiography. This study investigated whether statins…”
Get full text
Journal Article -
17
Effect of High-Dose Atorvastatin Reload on the Release of Endothelial Progenitor Cells in Patients on Long-Term Statin Treatment Who Underwent Percutaneous Coronary Intervention (from the ARMYDA-EPC Study)
Published in The American journal of cardiology (15-01-2016)“…Endothelial progenitor cells (EPCs) may concur to endogenous vascular repair. Previous studies have reported that statin treatment increases EPC levels. We…”
Get full text
Journal Article -
18
Switching of Platelet P2Y12 Receptor Inhibitors in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Review of the Literature and Practical Considerations
Published in The American heart journal (01-06-2016)“…Abstract The combination of aspirin and a P2Y12 receptor inhibitor is the cornerstone of treatment in patients with acute coronary syndromes (ACS) and in those…”
Get full text
Journal Article -
19
Left atrial appendage occlusion after thromboembolic events or left atrial appendage sludge during anticoagulation therapy: Is two better than one? Real‐world experience from a tertiary care hospital
Published in Journal of arrhythmia (01-06-2023)“…Background The role of left atrial appendage occlusion (LAAO) for atrial fibrillation patients that during oral anticoagulant therapy (OAC) suffer from…”
Get full text
Journal Article -
20
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study
Published in Frontiers in immunology (19-12-2022)“…Factors associated with long-term sequelae emerging after the acute phase of COVID-19 (so called "long COVID") are unclear. Here, we aimed to identify risk…”
Get full text
Journal Article